Ascendis Pharma A ASND
NASDAQ ASND
$270.67 -0.45 (-0.16%)
As of: Sep 4, 2026 · 3:59 PM EDT

Ascendis Pharma A (ASND) Beginning Cash Balance (2019 - 2021)

Analysis

Ascendis Pharma A (ASND) Beginning Cash Balance (2019 - 2021) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Ascendis Pharma A 16.39 Bn 15.45 Bn 362.22 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2021 817.18 Mn
Jun 30, 2021 463.09 Mn
Mar 31, 2021 597.14 Mn
Sep 30, 2020 891.77 Mn
Jun 30, 2020 265.02 Mn
Mar 31, 2020 589.92 Mn
Sep 30, 2019 732.91 Mn
Jun 30, 2019 775.71 Mn
Mar 31, 2019 791.85 Mn